JP2012502975A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502975A5
JP2012502975A5 JP2011527444A JP2011527444A JP2012502975A5 JP 2012502975 A5 JP2012502975 A5 JP 2012502975A5 JP 2011527444 A JP2011527444 A JP 2011527444A JP 2011527444 A JP2011527444 A JP 2011527444A JP 2012502975 A5 JP2012502975 A5 JP 2012502975A5
Authority
JP
Japan
Prior art keywords
pyrazole
carboxamide
cyanophenyl
isopropyl
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011527444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012502975A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/054038 external-priority patent/WO2010032200A1/en
Publication of JP2012502975A publication Critical patent/JP2012502975A/ja
Publication of JP2012502975A5 publication Critical patent/JP2012502975A5/ja
Withdrawn legal-status Critical Current

Links

JP2011527444A 2008-09-18 2009-09-16 治療において有用なアミド化合物 Withdrawn JP2012502975A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9790208P 2008-09-18 2008-09-18
US61/097,902 2008-09-18
PCT/IB2009/054038 WO2010032200A1 (en) 2008-09-18 2009-09-16 Amide compounds useful in therapy

Publications (2)

Publication Number Publication Date
JP2012502975A JP2012502975A (ja) 2012-02-02
JP2012502975A5 true JP2012502975A5 (enExample) 2012-10-25

Family

ID=41269630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011527444A Withdrawn JP2012502975A (ja) 2008-09-18 2009-09-16 治療において有用なアミド化合物

Country Status (20)

Country Link
US (2) US8232269B2 (enExample)
EP (1) EP2350017A1 (enExample)
JP (1) JP2012502975A (enExample)
KR (1) KR20110044304A (enExample)
CN (1) CN102159548A (enExample)
AP (1) AP2011005611A0 (enExample)
AU (1) AU2009294290B2 (enExample)
BR (1) BRPI0918935A2 (enExample)
CA (1) CA2735931A1 (enExample)
CL (1) CL2011000570A1 (enExample)
CO (1) CO6351734A2 (enExample)
DO (1) DOP2011000083A (enExample)
EA (1) EA201100368A1 (enExample)
EC (1) ECSP11010901A (enExample)
IL (1) IL211479A0 (enExample)
MA (1) MA32642B1 (enExample)
MX (1) MX2011002899A (enExample)
PE (1) PE20110793A1 (enExample)
WO (1) WO2010032200A1 (enExample)
ZA (1) ZA201102690B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5964407B2 (ja) * 2011-04-21 2016-08-03 オリオン コーポレーション アンドロゲン受容体調節カルボキシアミド
EP2734042B1 (en) * 2011-07-21 2017-02-01 The Regents Of The University Of California Targeting gli proteins in human cancer by small molecules
US9416109B2 (en) 2012-02-17 2016-08-16 Eisai R&D Management Co., Ltd. Methods and compounds useful in the synthesis of orexin-2 receptor antagonists
EP2700635A1 (en) 2012-08-20 2014-02-26 Basf Se 5-Trifluoromethylpyrazole amides having herbicidal activity
WO2014116651A1 (en) 2013-01-23 2014-07-31 The Regents Of The University Of California Targeting gli proteins in human cancer by small molecules
EA027879B1 (ru) 2013-02-22 2017-09-29 Пфайзер Инк. ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK)
WO2014143617A1 (en) * 2013-03-14 2014-09-18 Teva Women's Health, Inc. Deuterium-enriched tanaproget and processes for its preparation
WO2016024185A1 (en) 2014-08-12 2016-02-18 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
US20190321363A1 (en) * 2016-06-20 2019-10-24 Dr. Reddy's Laboratories Limited Process for the preparation of elagolix sodium and its polymorph
CN108623446A (zh) * 2017-03-24 2018-10-09 北京艾德旺科技发展有限公司 一种合成3,3-二氟环丁烷甲酸的方法
EP3946606B1 (en) 2019-03-27 2025-01-01 Insilico Medicine IP Limited Bicyclic jak inhibitors and uses thereof
EP4053124A1 (en) * 2019-10-28 2022-09-07 Shanghai Institute of Materia Medica, Chinese Academy of Sciences Five-membered heterocyclic oxocarboxylic acid compound and medical use thereof
WO2023217203A2 (zh) * 2022-05-12 2023-11-16 西北农林科技大学 二苯基吡唑类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2604218A1 (en) * 2005-04-20 2006-10-26 Pfizer Limited Pyrazole derivatives as progesterone receptor antagonists
CA2623327A1 (en) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same

Similar Documents

Publication Publication Date Title
AU2018360854B2 (en) Modulators of the integrated stress pathway
CN109641844B (zh) 整合应激通路的调节剂
KR102566924B1 (ko) 케모카인 수용체 조절제 및 이의 용도
CN109641854B (zh) 整合应激通路的调节剂
JP2013516415A5 (enExample)
JP6914933B2 (ja) ヤヌスキナーゼ、並びにその組成物及びその使用
CN114206848A (zh) 作为整合应激通路的调节剂的被取代的环烷基化合物
JP2014511869A5 (enExample)
KR20120062839A (ko) 단백질 키나제 억제제로서의 화합물 및 조성물
RU2016112952A (ru) Производные индола и индазола
RU2018127315A (ru) Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунологических и аутоиммунных заболеваний
RU2011125314A (ru) Новое производное пиразол-3-карбоксамида, обладающее антагонистической активностью в отношении рецептора 5-нт2в
JP2004502642A5 (enExample)
JP2014139226A5 (enExample)
JP2011524363A5 (enExample)
JPWO2016031815A1 (ja) 複素環化合物
JP2010514689A5 (enExample)
JP2019504901A5 (enExample)
JPWO2015016206A1 (ja) 複素環化合物
JP2012525431A5 (enExample)
JP2016510035A5 (enExample)
RU2007100136A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
CN107849044B (zh) 作为ddr1抑制剂的三氮杂-螺癸酮类化合物
RU2666730C2 (ru) Диазольные лактамы
JP2016503009A5 (enExample)